1stOncology™: Cancer Intelligence Service – Page 13834 – 1stOncology is recognized as a Top 10 Global Pharma Analytic Provider

Bellicum Pharmaceuticals to Report Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call and Webcast on Tuesday, March 12, 2019

On March 5, 2019 Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, reported that the Company will host a conference call and live webcast on Tuesday, March 12, 2019 at 5:00 p.m (Press release, Bellicum Pharmaceuticals, MAR 5, 2019, View Source [SID1234533955]). Eastern to report its fourth quarter and full year 2018 financial results and provide a corporate update.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

To access the call, participants should dial 877-407-3103 (U.S. domestic) and 201-493-6791 (international) at least 10 minutes prior to the start of the call. The event will be webcast live and can also be accessed in the Events & Presentations section of bellicum.com. An archived version of the webcast will be available for replay in the Investors & Media section of the Bellicum website for at least two weeks following the call.

Pieris Pharmaceuticals to Host Full-Year 2018 Investor Call and Corporate Update on March 12, 2019

On March 5, 2019 Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for respiratory, cancer and other diseases, reported that it will host a full-year 2018 investor call on Tuesday, March 12, 2019 at 8:00 AM (EDT) to discuss financial results and provide a corporate update (Press release, Pieris Pharmaceuticals, MAR 5, 2019, View Source [SID1234533954]).

To access the call, participants may dial 877-407-8920 (US & Canada) or 412-902-1010 (International) at least 10 minutes prior to the start of the call.

An archived replay of the call will be available for 30 days by dialing 877-660-6853 (Toll Free US & Canada) or 201-612-7415 (International) and providing the Conference ID #13661472.

FLX Bio to Present at Cowen and Company 39th Annual Health Care Conference

On March 5, 2019 FLX Bio, Inc., a clinical-stage, biopharmaceutical company focused on the development of oral small-molecule drugs that target immune drivers of cancer and other immune-related disorders, reported that Brian Wong, M.D., Ph.D., CEO will present a corporate update and company overview at the Cowen and Company 39thAnnual Health Care Conference on Monday, March 11, 2019 at 3:00 p.m. ET in Boston, MA (Press release, FLX Bio, MAR 5, 2019, http://www.flxbio.com/flxbio_presents_at_cown_and_co_2019/ [SID1234533953]).

A live webcast and audio archive of the presentation may be accessed here or on the FLX Bio website at View Source Please connect to the website 10 minutes prior to the presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast.

Unum Therapeutics to Present at the Cowen and Company 39th Annual Health Care Conference 2019

On March 5, 2019 Unum Therapeutics Inc. (NASDAQ: UMRX), a clinical-stage biopharmaceutical company focused on the development of cellular immunotherapies to treat cancer based on its novel T cell technology platforms, reported that Charles Wilson, Chief Executive Officer, will present a corporate overview at the Cowen and Company 39th Annual Health Care Conference 2019 on Tuesday, March 12, 2019 at 11:20 a.m. ET in Boston, Massachusetts (Press release, Unum Therapeutics, MAR 5, 2019, https://investors.unumrx.com/news-releases/news-release-details/unum-therapeutics-present-cowen-and-company-39th-annual-health [SID1234533950]).

The presentation will be webcast live, and available for replay on the "Events" section of Unum’s investor relations webpage (investors.unumrx.com/events) where it will be archived for approximately 90 days.

Bristol-Myers Squibb to Take Part in the Cowen and Company 39th Annual Health Care Conference

On March 5, 2019 Bristol-Myers Squibb Company (NYSE:BMY) reported that it will take part in a fireside chat at the Cowen and Company 39th Annual Health Care Conference on Tuesday, March 12, 2019, in Boston (Press release, Bristol-Myers Squibb, MAR 5, 2019, https://news.bms.com/press-release/corporatefinancial-news/bristol-myers-squibb-take-part-cowen-and-company-39th-annual-h [SID1234533949]). Giovanni Caforio, M.D., chairman and chief executive officer will answer questions at 11:20 a.m. ET.

Investors and the general public are invited to listen to a live webcast of the session at View Source Materials related to the presentation will be available at the same website at the start of the live webcast. An archived edition of the session will be available later that day.